13MO Safety and efficacy of tusamitamab ravtansine in combination with pembrolizumab ± chemotherapy in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05 phase II study)

Autor: Isambert, N., Nagy, T., Ravoire, M., Rodriguez-Abreu, D., Gonzalez-Larriba, J.L., Huang, C.H., Paz-Ares, L., Roubec, J., Rey, F., Robinet, G., Onn, A., Shamai, S., Bensfia, S., Soufflet, C., Chevance, A., Veillon, R.
Zdroj: In Journal of Thoracic Oncology April 2023 18(4) Supplement:S46-S47
Databáze: ScienceDirect